Charles Schwab Investment Management Inc Dyne Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$557 Billion
Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 745,071 shares of DYN stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

745,071

Previous 654,131 13.9%

Holding current value

$12.6 Million

Previous $6.84 Million 3.67%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$6.81 - $14.78 $619,301 - $1.34 Million	90,940 Added 13.9%	745,071 $7.09 Million
Q1 2025 Sep 15, 2025	SELL	$10.46 - $25.46 $951,232 - $2.32 Million	-90,940 Reduced 12.21%	654,131 $6.84 Million
Q1 2025 May 09, 2025	SELL	$10.46 - $25.46 $139,337 - $339,152	-13,321 Reduced 2.0%	654,131 $6.84 Million
Q4 2024 Feb 06, 2025	BUY	$23.56 - $35.55 $442,928 - $668,340	18,800 Added 2.9%	667,452 $15.7 Million
Q3 2024 Nov 12, 2024	BUY	$31.94 - $47.04 $1.52 Million - $2.24 Million	47,590 Added 7.92%	648,652 $23.3 Million
Q2 2024 Aug 12, 2024	BUY	$23.65 - $35.63 $3.3 Million - $4.97 Million	139,540 Added 30.23%	601,062 $21.2 Million
Q1 2024 May 08, 2024	BUY	$13.06 - $29.18 $1.7 Million - $3.79 Million	129,954 Added 39.19%	461,522 $13.1 Million
Q4 2023 Feb 06, 2024	BUY	$6.62 - $13.64 $41,024 - $84,527	6,197 Added 1.9%	331,568 $4.41 Million
Q3 2023 Nov 08, 2023	BUY	$8.6 - $12.18 $346,150 - $490,245	40,250 Added 14.12%	325,371 $2.92 Million
Q2 2023 Aug 09, 2023	BUY	$8.53 - $14.28 $490,790 - $821,628	57,537 Added 25.28%	285,121 $3.21 Million
Q1 2023 May 11, 2023	SELL	$10.88 - $15.0 $6,071 - $8,370	-558 Reduced 0.24%	227,584 $2.62 Million
Q4 2022 Feb 13, 2023	BUY	$9.37 - $13.8 $53,483 - $78,770	5,708 Added 2.57%	228,142 $2.64 Million
Q3 2022 Nov 14, 2022	BUY	$7.2 - $15.17 $311,623 - $656,572	43,281 Added 24.16%	222,434 $2.83 Million
Q2 2022 Aug 15, 2022	SELL	$4.36 - $10.5 $58,092 - $139,902	-13,324 Reduced 6.92%	179,153 $1.23 Million
Q1 2022 May 13, 2022	BUY	$6.52 - $12.27 $25,545 - $48,073	3,918 Added 2.08%	192,477 $1.86 Million
Q4 2021 Feb 11, 2022	BUY	$11.89 - $16.07 $52,030 - $70,322	4,376 Added 2.38%	188,559 $2.24 Million
Q3 2021 Nov 16, 2021	BUY	$15.6 - $21.46 $507,889 - $698,673	32,557 Added 21.47%	184,183 $2.99 Million
Q2 2021 Aug 16, 2021	BUY	$15.94 - $22.33 $464,395 - $650,562	29,134 Added 23.78%	151,626 $3.19 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $563,024 - $1.18 Million	40,216 Added 48.88%	122,492 $1.9 Million
Q4 2020 Feb 16, 2021	BUY	$16.81 - $23.94 $1.38 Million - $1.97 Million	82,276 New	82,276 $1.73 Million

Others Institutions Holding DYN

# of Institutions

212

Shares Held

122M

Call Options Held

36.5K

Put Options Held

74.3K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $878M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Dyne Therapeutics, Inc. Transaction History